Overview

Study of MAR001 in Adults With Elevated Triglycerides and Remnant Cholesterol

Status:
RECRUITING
Trial end date:
2026-12-01
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to evaluate the effect of MAR001 compared to placebo on levels of the TG and RC in adults with elevated TG and RC.
Phase:
PHASE2
Details
Lead Sponsor:
Marea Therapeutics
Collaborator:
The TIMI Study Group